Evaluate the Efficacy and Safety of KK8398 in Patients With Achondroplasia（AOBA Study）

NCT06926491 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Achondroplasia

Interventions

DRUG: KK8398

Sponsor

Kyowa Kirin Co., Ltd.